Found 398 matching trials
CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells PHASE1 The purpose of this study is to collect data on the safety and potential ef...
Show More Location
Roger Williams Medical Center
Learn More & Join Trial
CD4 CAR+ ZFN-modified T Cells in HIV Therapy PHASE1 This research study is being carried out to study a new way to possibly tre...
Show More Status
Active Not Recruiting
Location
University of Pennsylvania
Learn More & Join Trial
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer NA RATIONALE: Studying samples of blood and tissue from patients with cancer i...
Show More Location
Cancer Research UK at Cambridge Research Institute
Learn More & Join Trial
Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T N/A Long-term follow-up of study subjects who received AGT103-T product in HIV ...
Show More Status
Enrolling By Invitation
Location
Georgetown University
Learn More & Join Trial
Natural History in Fabry Disease With IVS4+919G>A Mutations N/A Fabry disease (FD) is a genetic condition where mutations in the GLA gene c...
Show More Status
Active Not Recruiting
Location
Division of Cardiology, Department of Medicine and Therapeutics Faculty of Medicine, The Chinese University of Hong Kong
Learn More & Join Trial
Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial
Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis PHASE2 This study is trying to evaluate the efficacy and safety of dose-modified E...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer PHASE1 The purpose of this study is to determine whether ETBX-021 is safe and effe...
Show More Location
Chan Soon-Shiong Institute for Medicine
Learn More & Join Trial
Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency PHASE1 The purpose of this study is to evaluate the safety and effectiveness of le...
Show More Location
Laboratory of Host Defenses (LHD), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
Learn More & Join Trial
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy PHASE4 This is an open-label, single-arm, multicenter clinical study to evaluate t...
Show More Location
University of Arkansas for Medical Sciences
Learn More & Join Trial